產(chǎn)品分類導(dǎo)航
2025制藥工業(yè)深圳展
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism
Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism

Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism

更新時間:2025-06-20

價格:  元/個
CAS號: 148866-44-3
藥典: 中國藥典,企業(yè)標準
級別: injection
立即詢盤
收藏
產(chǎn)品詳情
產(chǎn)品關(guān)鍵詞: GLP-1 Receptor Agonist,Diabetes Medication,Weight Management,Once-Daily Injection,Type 2 Diabetes Treatment
是否為生產(chǎn)商:
產(chǎn)品包裝規(guī)格: 10mg/Ampoule 15mg/Ampoule 20mg/Ampoule 10Ampoules/Box
供貨能力: 500000
主要銷售市場: 中國,北美洲,中/南美洲,西歐,東歐,大洋洲,亞洲,中東,非洲
產(chǎn)品描述:




Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog with 97% amino acid sequence homology to endogenous GLP-1. It functions through several key mechanisms:

  1. Insulin Secretion: Liraglutide binds to GLP-1 receptors on pancreatic beta cells, promoting glucose-dependent insulin secretion to lower blood glucose levels.
  2. Inhibition of Glucagon Secretion: It reduces the secretion of glucagon, thereby decreasing hepatic glucose production.
  3. Delayed Gastric Emptying: Liraglutide slows down gastric emptying, reducing the rapid absorption of glucose from the gastrointestinal tract.
  4. Appetite Regulation: By acting on the central appetite regulation centers in the brain, liraglutide suppresses appetite and increases satiety, leading to reduced food intake.
  5. Beta-Cell Protection: Liraglutide helps protect pancreatic beta-cell function by promoting beta-cell proliferation and reducing apoptosis.

Applications

Liraglutide is primarily used for:

  1. Type 2 Diabetes Treatment: It helps regulate blood glucose levels, reduces HbA1c, and lowers the risk of diabetes-related complications.
  2. Obesity Management: Approved for the treatment of obesity, liraglutide aids in weight loss by suppressing appetite and reducing food intake.
  3. Cardiovascular Protection: Some studies suggest that liraglutide may offer cardiovascular benefits.

Dosage Instructions

  1. For Type 2 Diabetes:The initial dose is typically 0.6 mg once daily, administered via subcutaneous injection.After one week, the dose can be increased to 1.2 mg daily, with a maximum recommended dose of 1.8 mg per day.
  2. For Obesity Treatment:The usual dose is 3.0 mg once daily, administered via subcutaneous injection.It is recommended to inject at the same time each day to maintain stable drug levels.

Storage

  1. Unopened Liraglutide: Should be stored refrigerated (2°C to 8°C) and protected from freezing.
  2. Opened Liraglutide: Can be stored at room temperature (not exceeding 25°C) for up to 28 days after opening.
  3. Avoid exposure to direct sunlight and high temperatures, and keep the medication out of reach of children and pets.


上海浦津林州制藥有限公司
注冊資本
聯(lián)系人
聯(lián)系電話
查看聯(lián)系方式
快速詢盤
詢盤主題
請輸入詢盤主題
詢盤信息
請輸入詢盤信息
滑動驗證
請完成滑塊驗證
快速發(fā)送詢盤
CPHI制藥在線為您找到Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism 價格、Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism 詳細參數(shù)、Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism 相關(guān)產(chǎn)品、Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism 供應(yīng)商等信息,想了解當前Liraglutide for Weight Loss: Harnessing the Power of GLP-1 Receptor Agonism 最新報價,請聯(lián)系上海浦津林州制藥有限公司。
2006-2025 上海博華國際展覽有限公司版權(quán)所有(保留一切權(quán)利) 滬ICP備05034851號-57